In keeping with our finding, data from the Human Protein Atlas showed that MPZL1 overexpression was associated with a poor prognosis in renal, liver, lung and thyroid cancers (www.proteinatlas.org/ENSG00000197965-MPZL1/pathology). Here, MPZL1 is linked to thyroid gland carcinoma.